Canada · Health Canada Drug Product Database
NOVAHISTINE DH
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16640
- DIN
- 02049473
- Form
- Syrup
- Company as listed by source
- SANOFI-AVENTIS CANADA INC
- Source status
- Cancelled Post Market (2020-07-10)
- Source last updated
- 2025-03-22
Source-listed ingredients
- HYDROCODONE BITARTRATE — 1.7 MG — per 5 ML
- PHENYLEPHRINE HYDROCHLORIDE — 10 MG — per 5 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 100/500ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →